Nuvectis Pharma, Inc. disclosed a transaction in an SEC filing while its stock traded on the Nasdaq exchange.
2 reports, 1 independent
Updated Aug 26
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Nuvectis Pharma, Inc. disclosed a transaction in an SEC filing while its stock traded on the Nasdaq exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Nuvectis Pharma conducted a secondary public offering.Sub-event
Nuvectis Pharma disclosed a transaction in SEC filing while trading on Nasdaq.1 source
Keep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
Related events
- Repay Holdings Corporation disclosed a transaction in an SEC filing and trades on Nasdaq.
- Universal Electronics Inc. disclosed a transaction in a legal filing with the SEC and its stock is traded on the Nasdaq exchange.
- Real Brokerage Inc., listed on Nasdaq, has disclosed market activity and trades with the Securities & Exchange Commission.
- Visteon filed transaction details with the SEC and traded on the Nasdaq stock exchange on June 6, 2026.
- BioLineRx Ltd. is utilizing the Nasdaq stock exchange for a registered direct offering, filing with the SEC.